Fungal Foes: Understanding the Challenges of Fungal Infections and New Treatment Options

While bacterial infections and viruses have captured the attention of the world, fungal diseases also pose a major threat to public health. With the rise in incidences of fungal infections and the reduced efficacy of antifungal drugs, there is an urgent need for the development of novel antifungal agents.

Explore the fascinating world of fungal pathogens and opportunistic species with Hongmin Li of The University of Arizona, Tucson and Sean Ekins of Collaborations Pharmaceuticals, Inc as they discuss two different, successful, and innovative approaches to antifungal drug discovery. Register now to find out how computational machine learning is currently being applied to antifungal drug discovery and how to identify alternative targets to overcome drug resistance in fungi.

This ACS Webinar is moderated by Rebecca E. Moore of ACS Publications and is co-produced with ACS Publications.

What You Will Learn

• The importance of studying fungal pathogens and an introduction to several opportunistic fungal species
• How computational machine learning can be used in antifungal drug discovery
• How to search for alternative targets in fungi to overcome drug resistance

Webinar Details

• Wednesday, March 13, 2024 @ 11am-12:30pm ET
• Free to register with ACS ID
• Slides will be available on the day of the live event

Meet The Experts

Hongmin Li, Professor, The University of Arizona, Tucson

Sean Ekins, CEO, Collaborations Pharmaceuticals, Inc.

Rebecca E. Moore, Assistant Managing Editor, ACS Publications